1 The e ects of two sigma (s) binding site ligands, (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), on bladder functions were examined in rats. 2 Cystometry using urethane-anaesthetized rats showed that (+)-pentazocine (1 ± 5 mg kg 71 , i.v.) and DTG (1 ± 5 mg kg 71 , i.v.) prolonged micturition intervals, indicating increased bladder capacity and raised the threshold pressure.3 The e ects of (+)-pentazocine (2 mg kg 71 , i.v.) on micturition were not in¯uenced by naloxone (0.5 mg kg 71 , i.v.), which antagonized similar e ects of morphine (2 mg kg 71 , i.v.). 4 When administered intracerebroventricularly (i.c.v.), DTG (1 mg) and (+)-pentazocine (30 mg) prolonged micturition intervals with increased threshold pressure on the cystometrogram. 5 In isolated bladder detrusor strips of rats, (+)-pentazocine (3 mM) and DTG (1 mM) did not a ect contractile responses to electrical ®eld stimulation. A higher concentration of DTG (3 mM) slightly suppressed the response induced by 30 Hz stimulation.6 The e ects of (+)-pentazocine and DTG on micturition were abolished by pre-treatment with pertussis toxin (PTX, 1 mg, i.c.v.). 7 These results indicate that typical s ligands, such as (+)-pentazocine and DTG, increase bladder capacity in anaesthetized rats. Moreover, the mechanism by which s ligands change the urinary storage properties in rats may involve pathways in which the function of Gi/o proteins is necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.